Skip to content
Independent analysis of NHS open data
PharmaInsight

Buserelin

Malignant Disease and Immunosuppression Sex hormones and hormone antagonists in malignant disease BNF 0803042B0
Data updated May 2026 Download CSV
2items

Dispensed in May 2026

3items

Rolling 12 months

£71

Net ingredient cost · May 2026

Figure 1. Buserelin: national items dispensed by month

0 3 6 Jan 2021 Apr 2021 Jul 2021 Oct 2021 Mar 2022 May 2023 May 2026 2 Jan 2021: 5 Feb 2021: 3 Mar 2021: 2 Apr 2021: 4 May 2021: 4 Jun 2021: 6 Jul 2021: 3 Aug 2021: 3 Sep 2021: 2 Oct 2021: 1 Nov 2021: 4 Jan 2022: 1 Mar 2022: 2 Jul 2022: 1 Nov 2022: 1 May 2023: 1 Dec 2024: 1 Jul 2025: 1 May 2026: 2

Source: NHSBSA Prescription Cost Analysis, to May 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Sex hormones and hormone antagonists in malignant disease
  • Presentations 1 shown
  • Average cost / item £35.25
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, May 2026

The individual products dispensed under Buserelin this month.

Presentations of Buserelin, May 2026
Presentation BNF code Items Net ingredient cost
Buserelin 5.5mg/5.5ml solution for injection vials(Prostate) 0803042B0AAAAAA 2 £71

Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0

Where Buserelin is dispensed

The regions and dispensing practices with the highest Buserelin volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Buserelin with

Other medicines in the same BNF section, by prescribing volume.